One study showed that lncRNA PVT1 was elevated in cisplatin resistant ovarian cancer tissues, while lncRNAs TUG1 and MEG3 were decreased in ovarian cancer patients with cisplatin resistance (El-Khazragy et al., 2020). Here, MEG3 is linked to ovarian carcinoma.